Neuromuscular Center

The University Hospital Zurich and the Children's Hospital Zurich have pooled their expertise to guarantee continuous, comprehensive diagnosis, treatment and support for children and adults with muscle and nerve disorders.

We attach great importance to the best diagnostics and treatment, but also to empathetic support for patients and their relatives. Intensive, interdisciplinary cooperation means that the best possible treatment can always be offered.

Neuromuscular diseases

Neuromuscular diseases can affect people at any age. They are often chronic and can lead to physical limitations and shortened life expectancy. In addition to the muscles themselves (myopathy), the nerves supplying the muscle (motor neuron disease and other neuropathies) or the signal transmission from the nerve to the muscle (myasthenia) can also be affected. Patients with neuromuscular diseases often suffer from rapid fatigue, paralysis and muscle atrophy, sometimes also from pain or changes in sensation as well as respiratory dysfunction.

Some neuromuscular diseases are congenital or inherited. The most common disease in children is Duchenne muscular dystrophy. One in 3,500 boys is affected by this disease, which begins in infancy with slight weakness of the legs and affects more and more muscle groups as the child grows older. Other congenital diseases can occur either in infancy or only in the course of time, e.g. congenital myopathies, certain limb-girdle muscular dystrophies or myotonic dystrophy.

Other neuromuscular diseases occur due to inflammation, infections, metabolic disorders or neurodegenerative diseases. The latter includes amyotrophic lateral sclerosis (ALS), in which the nerve cells (motor neurons) responsible for supplying the muscles with nerve impulses are affected. This also includes chronic inflammation of the muscles (polymyositis) or nerves (chronic inflammatory demyelinating polyneuropathy; CIDP).

Additional examinations

Electroneurography (ENG), electromyography (EMG)

If required, additional examinations such as electroneurography (ENG), electromyography (EMG), examinations of the neuromuscular end plate (repetitive stimulation, stimulated single-fiber EMG), motor-evoked potentials (MEP), electrophysiological testing of autonomic functions (sympathetic sudomotor stimulus response, R-R interval variation), metabolic examinations including metabolic function tests as well as nerve and muscle biopsies are carried out.

To the ENMG consultation

Amyotrophic lateral sclerosis (ALS)

The Neuromuscular Center Zurich has a specialized ALS consultation hour where our patients are cared for and treated by the medical team. We are the point of contact not only for medical questions, but also for nursing, social and psychological issues and, if necessary, arrange appropriate support services close to home.

Contact

mail muskel@usz.ch
Tel. +41 44 255 55 20

Amyotrophic lateral sclerosis registry study

Have you been diagnosed with amyotrophic lateral sclerosis (ALS) and would you like to contribute to ALS research? Then why not register for the ALS Registry Switzerland? This is a Swiss-wide registry study initiated by the University Hospital Zurich and currently being conducted in collaboration with several Swiss hospitals (Ente Ospedaliero Cantonale Lugano, Hôpitaux universitaires de Genève, Kantonsspital Luzern). For participation or further information, please contact our study coordinator by telephone on +41 44 255 55 20 (Monday all day, Tuesday – Friday morning) or send us an e-mail to jan.loosli@usz.ch

Teaching and research

The scientific focus of the Neuromuscular Center Zurich is the investigation of the influence of physical training on muscle characteristics and the course of neuromuscular and neurodegenerative diseases. A project to investigate the effect of physical training on patients with Huntington’s disease is currently being funded by the Swiss National Science Foundation (SNSF).

Clinical-pathological case conferences are held regularly, twice a year with the participation of specialists from other Swiss muscle centers, and the Neuromuscular Symposium is held annually.

  1. Hof D, Jung HH, Bloch KE (2012). Troponin T elevation in amyotrophic lateral sclerosis without cardiac damage. Amyotrophic Lat Scler in press
  2. Jung HH, Neumann M, Bloch KE. Amyotrophic lateral sclerosis – diagnosis and therapy. Practice 101: 907-914
  3. Weber M, Neuwirth C, Thierbach J, Schweikert K, Czaplinski A, Petersen J, Jung HH, Birve A, Marklund S, Andersen PM (2012) Familial ALS patients with SOD mutations in Switzerland show very diverse phenotypes and extreme long survival. J Neurol Neurosurg Psychiatr 83: 351-353
  4. Jung HH, Danek A, Walker RH (2011) Neuroacanthocytosis syndromes. Orphanet J Rare Dis 6:68
  5. Gantenbein A, Damon-Perrière N, Bohlender JE, Chauveau M, Latxague C, Miranda M, Jung HH. Tison F (2011) Feeding dystonia in McLeod syndrome. Mov Disord 26: 2123-2126
  6. Walterfang M, Evans A, Looi J, Jung HH, Danek A, Walker R, Velakoulis D (2011) The neuropsychiatriy of neuroacanthocytosis syndromes. Neurosci Biobehav Rev 35: 1275-1283
  7. Kühnlein P, Jung H, Farkas M, Keskitalo S, Ineichen B, Jelcic I, Petersen J, Semmler A, Weller M, Ludolph AC, Linnebank M (2011) The thermolabile variant of 5,10-methylenetetrahydrofolate reductase is a possible risk factor for amyotrophic lateral sclerosis. Amyotroph Lat Sc 12: 136-139
  8. Wegener S, Bremer J, Komminoth P, Jung HH, Weller M (2010) Paraneoplastic necrotizing myopathy with a mild inflammatory component: a case report and review of the literature. Case Rep Oncol 3: 88-92
  9. Schwager S, Hochuli M, Jung HH (2010) Muscle weakness: differential diagnosis and clarification. Practice 99: 587-596
  10. Valko PO, Hänggi J, Meyer M, Jung HH (2010). Evolution of striatal degeneration in McLeod syndrome. Eur J Neurol 2010; 17: 612-618
  11. Ramseier SP, Jung HH (2010). Wilson Disease. Practice 99: 175-182
  12. Oechslin E, Kaup D, Jenni R, Jung HH (2009). Cardiac abnormalities in McLeod syndrome. Int J Cardiol 132; 130-132
  13. Hewer E, Danek A, Schoser BG, Miranda M, Reichard R, Castiglioni C, Oechsner M, Goebel HH, Heppner FL, Jung HH (2007). McLeod myopathy revisited – more neurogenic and less benign. Brain 130: 3285-3296
  14. Jung HH, Danek A, Frey BM (2007) McLeod syndrome – a neurohaematological disorder. Vox Sang 93: 112-121
  15. Walker RH, Jung HH, Dobson-Stone C, Rampoldi L, Sano A, Tison F, Danek A (2007) Neurologic phenotypes associated with acanthocytosis. Neurology 68:92-98
  16. Dydak U, Mueller S, Sandor PS, Meier D, Boesiger P, Jung HH (2006) Cerebral metabolic alterations in McLeod syndrome. Eur Neurol 56:17-23

Responsible professionals

Hans Heinrich Jung, Prof. Dr. med.

Senior Physician, Department of Neurology

Tel. +41 44 255 55 20
Specialties: Neuromuscular diseases, Dementia / Memory Clinic, Neurogenetic diseases / neurological rare diseases

Bettina Schreiner, PD Dr. med.

Senior Attending Physician, Department of Neurology

Tel. +41 44 255 55 20
Specialties: Inflammatory/ neuromuscular diseases, Myasthenia gravis, Neuroimmunology, multiple sclerosis

Heiko Pohl, MHD, PD Dr. med.

Attending Physician, Department of Neurology

Tel. +41 44 255 55 11

For patients

As a patient, you cannot register directly for a consultation. Please get a referral from your primary care physician, specialist.

For referrering physicians

Easily assign your patient online.

University Hospital Zurich
Department of Neurology
Neuromuscular Center
Frauenklinikstrasse 26
8091 Zurich

Tel. +41 44 255 55 20
Patient registration form

Responsible Department